- Home
- AMRN vs TSVT Comparison
AMRN vs TSVT Comparison
Compare AMRN & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- TSVT
- Stock Information
- Founded
- AMRN 1989
- TSVT 2021
- Country
- AMRN Ireland
- TSVT United States
- Employees
- AMRN N/A
- TSVT N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- AMRN Health Care
- TSVT Health Care
- Exchange
- AMRN Nasdaq
- TSVT Nasdaq
- Market Cap
- AMRN 216.0M
- TSVT 258.9M
- IPO Year
- AMRN 1993
- TSVT N/A
- Fundamental
- Price
- AMRN $10.41
- TSVT $4.99
- Analyst Decision
- AMRN Sell
- TSVT Buy
- Analyst Count
- AMRN 2
- TSVT 4
- Target Price
- AMRN $7.00
- TSVT $6.50
- AVG Volume (30 Days)
- AMRN 116.9K
- TSVT 726.2K
- Earning Date
- AMRN 05-07-2025
- TSVT 05-07-2025
- Dividend Yield
- AMRN N/A
- TSVT N/A
- EPS Growth
- AMRN N/A
- TSVT N/A
- EPS
- AMRN N/A
- TSVT N/A
- Revenue
- AMRN $214,112,000.00
- TSVT $48,365,000.00
- Revenue This Year
- AMRN N/A
- TSVT $84.48
- Revenue Next Year
- AMRN $0.89
- TSVT $9.69
- P/E Ratio
- AMRN N/A
- TSVT N/A
- Revenue Growth
- AMRN N/A
- TSVT N/A
- 52 Week Low
- AMRN $7.00
- TSVT $2.29
- 52 Week High
- AMRN $20.60
- TSVT $5.30
- Technical
- Relative Strength Index (RSI)
- AMRN 53.84
- TSVT 71.10
- Support Level
- AMRN $9.44
- TSVT $4.97
- Resistance Level
- AMRN $11.44
- TSVT $4.99
- Average True Range (ATR)
- AMRN 0.85
- TSVT 0.01
- MACD
- AMRN -0.01
- TSVT -0.04
- Stochastic Oscillator
- AMRN 47.09
- TSVT 50.00
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.